Access cutting-edge interstitial lung disease treatment through this clinical trial at a research site in St Louis. Study-provided care at no cost to qualified participants.
Access interstitial lung disease specialists in St Louis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related interstitial lung disease treatment provided free
Interstitial lung disease (ILD) is a lung condition resulting in inflammation and stiffening of the lung, often associated with connective tissue diseases (CTDs). ILD causes reduction in lung volume, shortness of breath, cough and fatigue therefore has high impact on quality of life and is also the leading cause of death in participants with these conditions. The study will assess whether treatment of CTD-ILD participants with belimumab in addition to standard therapy will result in the stabiliz
Sponsor: GlaxoSmithKline
Check if you qualify for this interstitial lung disease clinical trial in St Louis, MO
If you're searching for interstitial lung disease treatment options in St Louis, MO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our St Louis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced interstitial lung disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.